Organisme : Société de recherche sur le cancer
	Projets financés à l'Université Laval
		Amino acid neurotransmitter reprogramming of the tumour microenvironment and metabolism in glioblastoma
		Anti-PEG antibodies and adverse reactions to PEGylated drugs: effect of mRNA vaccination and novel mitigation strategies.
		Assessment of a novel TLR7/8 agonist in lung cancer
		Circulating basophils and eosinophils as novel biomarkers for non-muscle invasive cancer bladder cancer
		Identifying epithelial-to-mesenchymal transition effectors in aggressive basal cell carcinoma
		Impact of 2-hydroxyglutarate-induced astrocytes reactivity in low-grade glioma progression and recurrence
		Targeting the prostate cancer metabolic program established upon loss of the KLF5 gene
		Targeting the sonic hedgehog medulloblastoma metabolic program for therapeutic purposes
		The effect of cannabinoid receptors on breast cancer survival
		UGT2B28 IS A PROGNOSTIC AND PREDICTIVE BIOMARKER IN PROSTATE CANCER
		Unveiling the roles of Poly(ADP)ribose Glycohydrolase (PARG) in DNA repair and cancer